Valuation: Myomo, Inc.

Market Cap 37.48M 32.92M 30.61M 28.09M 52.78M 3.61B 53.6M 364M 142M 1.77B 141M 138M 6.14B P/E 2026 *
-3.17x
P/E 2027 * -4.08x
Enterprise Value 37.48M 32.92M 30.61M 28.09M 52.78M 3.61B 53.6M 364M 142M 1.77B 141M 138M 6.14B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 0.75x
Free-Float
89.54%
Yield 2026 *
-
Yield 2027 * -
1 day-3.00%
1 week+2.09%
Current month-6.73%
1 month-10.19%
3 months+17.66%
6 months+6.32%
Current year+6.59%
1 week 0.88
Extreme 0.8801
1.06
1 month 0.88
Extreme 0.8801
1.22
Current year 0.6
Extreme 0.605
1.59
1 year 0.6
Extreme 0.605
2.14
3 years 0.5
Extreme 0.4966
7.17
5 years 0.37
Extreme 0.369
14.35
10 years 0.37
Extreme 0.369
695.89
Manager TitleAgeSince
Chief Executive Officer 72 2011-06-30
Director of Finance/CFO 64 2019-02-17
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2016-07-31
Director/Board Member 79 2012-02-29
Director/Board Member 80 2014-08-31
Date Insider Type Main position Quantity % Market Cap.
7/13/26 Tax

Chief Financial Officer

-5,166 0.0134%
7/10/26 Free

Chief Executive Officer

10,454 0.0271%
6/25/26 Free

Director

78,704 0.2037%
Change 5-day change 1-year change 3-year change Capi.($)
-3.00%+2.09%-54.03%+21.45% 37.48M
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +0.19%-1.80%-7.46%+1.32% 54.4B
Weighted average by Cap. +1.28%-0.40%-6.81%+1.12%

Financials

2026 *2027 *
Net sales 44.43M 39.03M 36.29M 33.3M 62.58M 4.28B 63.54M 431M 168M 2.1B 167M 163M 7.27B 50.19M 44.08M 40.99M 37.62M 70.68M 4.83B 71.77M 487M 190M 2.38B 188M 184M 8.22B
Net income -13.04M -11.46M -10.65M -9.78M -18.37M -1.26B -18.65M -127M -49.43M -618M -48.97M -47.91M -2.14B -10.68M -9.38M -8.73M -8.01M -15.04M -1.03B -15.28M -104M -40.48M -506M -40.1M -39.24M -1.75B
Net Debt - -
Logo Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Employees
195
Date Price Change Volume
26-07-24 US$0.9700 -3.00% 262,443
26-07-23 US$1.000 -3.85% 117,566
26-07-22 US$1.040 +11.23% 334,122
26-07-21 US$0.9350 +3.89% 226,052
26-07-20 US$0.9000 -5.27% 380,490
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.9700USD
Average target price
4.420USD
Spread / Average Target
+355.67%

Quarterly revenue - Rate of surprise